Abstract:With the wide adoption of genomic sequencing in children having seizures, an increasing number of SCN2A genetic variants have been revealed as genetic causes of epilepsy. Voltage-gated sodium channel Nav1.2, encoded by gene SCN2A, is predominantly expressed in the pyramidal excitatory neurons and supports action potential (AP) firing. One recurrent SCN2A genetic variant is L1342P, which was identified in multiple patients with epileptic encephalopathy and intractable seizures. However, the mechanism underlying L1342P-mediated seizures and the pharmacogenetics of this variant in human neurons remain unknown. To understand the core phenotypes of the L1342P variant in human neurons, we took advantage of a reference human-induced pluripotent stem cell (hiPSC) line from a male donor, in which L1342P was introduced by CRISPR/Cas9-mediated genome editing. Using patch-clamping and microelectrode array (MEA) recordings, we revealed that cortical neurons derived from hiPSCs carrying heterozygous L1342P variant have significantly increased intrinsic excitability, higher sodium current density, and enhanced bursting and synchronous network firing, suggesting hyperexcitability phenotypes. Interestingly, L1342P neuronal culture displayed a degree of resistance to the anticonvulsant medication phenytoin, which recapitulated aspects of clinical observation of patients carrying the L1342P variant. In contrast, phrixotoxin-3 (PTx3), a Nav1.2 isoform-specific blocker, can potently alleviate spontaneous and chemically-induced hyperexcitability of neurons carrying the L1342P variant. Our results reveal a possible pathogenic underpinning of Nav1.2-L1342P mediated epileptic seizures and demonstrate the utility of genome-edited hiPSCs as an in vitro platform to advance personalized phenotyping and drug discovery.SIGNIFICANCE STATEMENT A mounting number of SCN2A genetic variants have been identified from patients with epilepsy, but how SCN2A variants affect the function of human neurons contributing to seizures is still elusive. This study investigated the functional consequences of a recurring SCN2A variant (L1342P) using human iPSC-derived neurons and revealed both intrinsic and network hyperexcitability of neurons carrying a mutant Nav1.2 channel. Importantly, this study recapitulated elements of clinical observations of drug-resistant features of the L1342P variant, and provided a platform for in vitro drug testing. Our study sheds light on cellular mechanism of seizures resulting from a recurring Nav1.2 variant, and helps to advance personalized drug discovery to treat patients carrying pathogenic SCN2A variant.

The absence of NIPA2 enhances neural excitability through BK (big potassium) channels.

Functional Study of NIPA2 Mutations Identified from the Patients with Childhood Absence Epilepsy.

Functional changes of voltage-dependent sodium channel on hippocampal neurons from rats with cortical developmental disabilities

NIPA2 located in 15q11.2 is mutated in patients with childhood absence epilepsy

The Epilepsy of Infancy With Migrating Focal Seizures: Identification of de novo Mutations of the KCNT2 Gene That Exert Inhibitory Effects on the Corresponding Heteromeric KNa1.1/KNa1.2 Potassium Channel

Impaired excitability of fast-spiking neurons in a novel mouse model of KCNC1 epileptic encephalopathy

Functional Characterization and Neuronal Modeling of the Effects of Childhood Absence Epilepsy Variants of CACNA1H, a T-type Calcium Channel.

De Novo BK Channel Mutation Causes Epilepsy by Regulating Voltage-Dependent, but Not Calcium-Dependent, Activation

CaV3.2 Calcium Channels Control NMDA Receptor-Mediated Transmission: a New Mechanism for Absence Epilepsy.

Plural molecular and cellular mechanisms of pore domain KCNQ2 encephalopathy

Severe Deficiency of the Voltage-Gated Sodium Channel NaV1.2 Elevates Neuronal Excitability in Adult Mice

Neddylation Stabilizes Nav1.1 to Maintain Interneuron Excitability and Prevent Seizures in Murine Epilepsy Models

Hyperexcitability and Pharmacological Responsiveness of Cortical Neurons Derived from Human Ipscs Carrying Epilepsy-Associated Sodium Channel Nav1.2-L1342P Genetic Variant.

Effect of Connexin 36 Blockers on the Neuronal Cytoskeleton and Synaptic Plasticity in Kainic Acid-Kindled Rats

Molecular Mechanisms of Epileptic Encephalopathy Caused by KCNMA1 Loss-of-Function Mutations

Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice

Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy

Altered PKA Modulation in the Nav1.1 Epilepsy Variant I1656M

Functional characterization and in vitro pharmacological rescue of KCNQ2 pore mutations associated with epileptic encephalopathy

Targeting Heterozygous Dominant Negative Variant of KCNA2 Using Gapmer ASO for the Treatment of Drug-Resistant Epilepsy

Functional characterization of a KCNAB3 genetic epilepsy with febrile seizures plus adult mouse model